SDH mutations, as potential predictor of chemotherapy prognosis in small cell lung cancer patients

PURPOSE: Small cell lung cancer (SCLC) is an aggressive and rapidly progressive malignant tumor characterized by a poor prognosis. Chemotherapy remains the primary treatment in clinical practice; however, reliable biomarkers for predicting chemotherapy outcomes are scarce. METHODS: In this study, 78...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Ran, Fan, Xiaoyun, Yang, Jin, Fang, Chen, Li, Jieyi, Wen, Wei, Liu, Jing, Lv, Mengchen, Feng, Xiangran, Zhao, XiaoKai, Yu, Hongjie, Zhang, Yuhuan, Sun, Xianwen, Bao, Zhiyao, Zhou, Jun, Ni, Lei, Wang, Xiaofei, Cheng, Qijian, Gao, Beili, Gong, Ziying, Zhang, Daoyun, Dong, Yuchao, Xiang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241767/
https://www.ncbi.nlm.nih.gov/pubmed/37273084
http://dx.doi.org/10.1007/s12672-023-00685-4

Ejemplares similares

Ejemplares similares